175 related articles for article (PubMed ID: 27720385)
1. Use of Granulocyte Colony-Stimulating Factor in a Neutropenic HIV-Infected Patient on Clozapine.
Elmore H; Lewin J; Bradley M; Sinkman A
Psychosomatics; 2016; 57(6):651-654. PubMed ID: 27720385
[No Abstract] [Full Text] [Related]
2. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
[No Abstract] [Full Text] [Related]
3. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
4. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Myles N; Myles H; Clark SR; Bird R; Siskind D
Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
[TBL] [Abstract][Full Text] [Related]
5. Clozapine re-challenge under the cover of Filgrastim.
Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
[TBL] [Abstract][Full Text] [Related]
6. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
Mathewson KA; Lindenmayer JP
J Clin Psychopharmacol; 2007 Dec; 27(6):714-5. PubMed ID: 18004146
[No Abstract] [Full Text] [Related]
7. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case report.
Spencer BW; Williams HR; Gee SH; Whiskey E; Rodrigues JP; Mijovic A; MacCabe JH
J Psychopharmacol; 2012 Sep; 26(9):1280-2. PubMed ID: 22719015
[TBL] [Abstract][Full Text] [Related]
9. Effects of granulocyte-colony-stimulating factor in neutropenic AIDS-patients.
Goebel FD; Bogner JR; Matuschke A; Heinrich B; Kronawitter U
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():357-60. PubMed ID: 1284306
[No Abstract] [Full Text] [Related]
10. Continuing clozapine despite recurrent neutropenia: A 8 year follow-up case report with granulocyte-colony stimulating factor as-required use.
Demers MF; Fortier L; Corbeil O; Breault AS; Roy MA
Asian J Psychiatr; 2020 Feb; 48():101541. PubMed ID: 30314715
[No Abstract] [Full Text] [Related]
11. Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia.
Clumeck N; Wit SD; Hermans P; Franchioly P; Sommereijns B
J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():353-6. PubMed ID: 1284305
[No Abstract] [Full Text] [Related]
12. Treatment of neutropenic oral ulceration in human immunodeficiency virus infection with G-CSF.
Luzzi GA; Jones BJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jan; 81(1):53-4. PubMed ID: 8850484
[TBL] [Abstract][Full Text] [Related]
13. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
Chan KSW; Lai NBW; Wong MMC; Pang PF
East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and chemotherapy: a dangerous couple or a necessary partnership?
Campbell G; Wong E
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318257
[TBL] [Abstract][Full Text] [Related]
15. Biopharmaceutical drug development: Filgrastim (r-metHuG-CSF) use in patients with HIV infection.
Foote M; Welch W
J Hematother Stem Cell Res; 1999; 8 Suppl 1():S3-8. PubMed ID: 10596029
[TBL] [Abstract][Full Text] [Related]
16. The use of GM-CSF in AIDS.
Scadden DT
Infection; 1992; 20 Suppl 2():S103-6. PubMed ID: 1283604
[TBL] [Abstract][Full Text] [Related]
17. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
van de Loosdrecht AA; Faber HJ; Hordijk P; Uges DR; Smit A
Neth J Med; 1998 Jan; 52(1):26-9. PubMed ID: 9573739
[TBL] [Abstract][Full Text] [Related]
18. [Administration of granulocyte colony-stimulating factor in patients infected with human immunodeficiency virus and prolonged neutropenia].
von Wichmann MA; Camino X; Txoperena G; Arrizabalaga J; RodrÃguez-Arrondo F; Iribarren JA
Enferm Infecc Microbiol Clin; 2001 Jan; 19(1):19-23. PubMed ID: 11256242
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-induced neutropenia in children: management with lithium carbonate.
Sporn A; Gogtay N; Ortiz-Aguayo R; Alfaro C; Tossell J; Lenane M; Gochman P; Rapoport JL
J Child Adolesc Psychopharmacol; 2003; 13(3):401-4. PubMed ID: 14642024
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine.
Sperner-Unterweger B; Czeipek I; Gaggl S; Geissler D; Spiel G; Fleischhacker WW
Br J Psychiatry; 1998 Jan; 172():82-4. PubMed ID: 9534838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
